Luther King Capital Management (LKCM)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-16,434
Closed -$1.02M 605
2022
Q3
$1.02M Sell
16,434
-40,492
-71% -$2.51M 0.01% 375
2022
Q2
$4.54M Buy
56,926
+42,201
+287% +$3.37M 0.03% 192
2022
Q1
$1.55M Buy
14,725
+4,695
+47% +$494K 0.01% 339
2021
Q4
$1.08M Buy
10,030
+370
+4% +$39.9K ﹤0.01% 401
2021
Q3
$1.06M Sell
9,660
-585
-6% -$64.1K 0.01% 402
2021
Q2
$959K Sell
10,245
-225
-2% -$21.1K ﹤0.01% 429
2021
Q1
$964K Hold
10,470
0.01% 395
2020
Q4
$766K Sell
10,470
-2,455
-19% -$180K ﹤0.01% 402
2020
Q3
$1M Sell
12,925
-2,375
-16% -$184K 0.01% 330
2020
Q2
$850K Sell
15,300
-112,140
-88% -$6.23M 0.01% 340
2020
Q1
$3.78M Sell
127,440
-14,780
-10% -$438K 0.03% 176
2019
Q4
$5.15M Sell
142,220
-245
-0.2% -$8.87K 0.03% 179
2019
Q3
$3.88M Buy
142,465
+22,780
+19% +$620K 0.03% 197
2019
Q2
$2.88M Buy
119,685
+37,675
+46% +$907K 0.02% 229
2019
Q1
$2.17M Buy
+82,010
New +$2.17M 0.02% 258